Stroke
From the Journals
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
Literature Review
Combination of Rivaroxaban and Aspirin Improves Cardiovascular Outcomes
Compared with aspirin alone, a regimen of rivaroxaban plus aspirin is associated with better cardiovascular outcomes among patients with stable...
Conference Coverage
How Low Can Cholesterol Safely Go?
BARCELONA—Very aggressive reduction of LDL-cholesterol to ultralow levels is associated with progressively fewer cardiovascular events and appears...
Conference Coverage
Higher BP targets suggested for elderly, cognitively impaired
SAN FRANCISCO – The price of lowering blood pressure in the elderly may be cognitive decline and even Alzheimer’s disease, one expert says.
Latest News
No benefit seen for routine low-dose oxygen after stroke
The large SO2S trial found no benefit for continuous or night-only routine oxygen supplementation.
Literature Review
Multifaceted Intervention Improves Anticoagulant Use in Patients With Atrial Fibrillation
A customized educational intervention significantly increases the use of oral anticoagulants among patients with atrial fibrillation at risk for...
Conference Coverage
VIDEO: Educational intervention boosts A fib anticoagulation
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
From the Journals
Patent foramen ovale closure reduces risk of stroke in three trials
Risks of procedure must be weighed against the benefit of reduced stroke risk.
News from the FDA/CDC
Recent upturn seen in stroke death rate
Long-term decline ended in 2013; reasons for the reversal “are not clear.”
Conference Coverage
VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients
BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,”...
Conference Coverage
New findings from first all-female TAVR registry
PARIS – Preprocedural atrial fibrillation is associated with bad outcomes at 1 year.